Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Mastocytosis × avapritinib × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 4 Neoplasm Metastasis 2 Systemic Mastocytosis With an Associated Hematologic Neoplasm 1 Sarcoma 1 Recurrence 1 Neoplasm, Residual 1 Melanoma 1 Mastocytosis, Systemic 1 Mastocytosis 1 Lung Neoplasms 1 Colorectal Neoplasms 1

Interventions

avapritinib 1 Watchful Waiting 1 Mass Screening 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07255638 2026-02-10

A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany

Blueprint Medicines Corporation

Mastocytosis, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡